NeuSpera Medical closed an $9 million round of equity financing, according to a new SEC filing from the company.
NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology.
The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices.
The money came from 4 anonymous investors, according to an SEC filing, and the company has not yet said how it intends to use the funds raised during the round. The company announced the round in May, after raising $8 million of the total.
Previous to this most recent round of financing, NeuSpera said it had raised more than $1 million in angel funding.
In August, NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it geared up to raise a Series A round for its neuromodulation technology.
The post Neuspera closes $9m funding round appeared first on MassDevice.
from MassDevice http://ift.tt/1tp4OBD
Cap comentari:
Publica un comentari a l'entrada